Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
Some people can experience temporary hair loss when they lose weight, but it usually only lasts for about 6 months
So, that could cost more than $16,000 a year if paid out-of-pocket for those whose insurance doesnt cover it
Can You Take Ozempic With Hashimoto's Disease
Ideal for patients needing a motivational boost at the start of their journey 4